KIDS vs. SILK, FNA, ATRI, EMBC, SIBN, OFIX, IRMD, AORT, BVS, and SRDX
Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Silk Road Medical (SILK), Paragon 28 (FNA), Atrion (ATRI), Embecta (EMBC), SI-BONE (SIBN), Orthofix Medical (OFIX), Iradimed (IRMD), Artivion (AORT), Bioventus (BVS), and Surmodics (SRDX). These companies are all part of the "surgical & medical instruments" industry.
Silk Road Medical (NASDAQ:SILK) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, community ranking, valuation, risk and institutional ownership.
Silk Road Medical currently has a consensus price target of $22.55, suggesting a potential upside of 1.65%. OrthoPediatrics has a consensus price target of $45.50, suggesting a potential upside of 42.10%. Given Silk Road Medical's stronger consensus rating and higher probable upside, analysts plainly believe OrthoPediatrics is more favorable than Silk Road Medical.
OrthoPediatrics received 216 more outperform votes than Silk Road Medical when rated by MarketBeat users. Likewise, 64.56% of users gave OrthoPediatrics an outperform vote while only 50.56% of users gave Silk Road Medical an outperform vote.
In the previous week, Silk Road Medical and Silk Road Medical both had 2 articles in the media. OrthoPediatrics' average media sentiment score of 1.03 beat Silk Road Medical's score of 0.00 indicating that Silk Road Medical is being referred to more favorably in the media.
Silk Road Medical has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500.
OrthoPediatrics has lower revenue, but higher earnings than Silk Road Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Silk Road Medical, indicating that it is currently the more affordable of the two stocks.
OrthoPediatrics has a net margin of -13.58% compared to OrthoPediatrics' net margin of -29.02%. Silk Road Medical's return on equity of -5.12% beat OrthoPediatrics' return on equity.
69.1% of OrthoPediatrics shares are held by institutional investors. 6.7% of Silk Road Medical shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
OrthoPediatrics beats Silk Road Medical on 11 of the 17 factors compared between the two stocks.
Get OrthoPediatrics News Delivered to You Automatically
Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OrthoPediatrics Competitors List
Related Companies and Tools
